文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

危重型COVID-19中的急性肾损伤:比利时七家大医院的多中心队列分析

Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium.
PubMed 文献 · Crit Care · 2022-07-25
一句话结论危重型COVID-19患者中超过80%发生急性肾损伤,主要由尿量标准驱动,所有AKI分期均与ICU死亡率相关。

该多中心回顾性队列分析纳入比利时七家大医院的1286例危重型COVID-19患者,按KDIGO标准评估入住ICU后21天内的急性肾损伤(AKI)。结果显示85.1%发生AKI,9.8%使用肾脏替代治疗(KRT);基于血肌酐诊断AKI者占40.1%,基于尿量者占81.5%。高龄、肥胖、较高APACHE II评分及ICU第1天机械通气与AKI风险增加相关;多因素调整后所有AKI分期均与ICU死亡率相关,基于血肌酐的所有分期及基于尿量的AKI 3期与ICU死亡率相关。持续性AKI占88.6%,急性肾脏病(AKD)占87.6%,AKI快速逆转者预后优于持续性AKI和AKD,存活AKI患者中47.4%实现肾脏恢复。

要点

  • 1286例危重型COVID-19患者中85.1%发生AKI,9.8%使用KRT,尿量标准诊断的AKI占81.5%,血肌酐标准仅占40.1%。
  • 多因素调整后所有AKI分期均与ICU死亡率相关;基于血肌酐的所有AKI分期及基于尿量的AKI 3期与ICU死亡率相关。
  • 高龄、肥胖、较高APACHE II评分及ICU第1天机械通气与AKI风险增加相关。
  • 持续性AKI占88.6%,AKD占87.6%;AKI快速逆转者预后优于持续性AKI和AKD。
  • 存活AKI患者中47.4%实现肾脏恢复。

适用人群与场景

  • 比利时七家大医院的危重型COVID-19患者,共1286例。

诊断标准与关键阈值

  • AKI按KDIGO标准定义,评估入住ICU后21天内。

研究设计与关键结果

  • 多中心回顾性队列分析,纳入比利时七家大医院1286例危重型COVID-19患者,AKI按KDIGO标准定义于入住ICU后21天内。
  • 1286例中85.1%发生AKI,9.8%使用KRT;基于血肌酐诊断AKI者占40.1%,基于尿量者占81.5%。
  • 高龄、肥胖、较高APACHE II评分及ICU第1天机械通气与AKI风险增加相关。
  • 多因素调整后所有AKI分期均与ICU死亡率相关;基于血肌酐的所有AKI分期及基于尿量的AKI 3期与ICU死亡率相关。
  • 持续性AKI占88.6%,AKD占87.6%;AKI快速逆转者预后优于持续性AKI和AKD。
  • 存活AKI患者中47.4%实现肾脏恢复。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute kidney injury (AKI) has been reported as a frequent complication of critical COVID-19. We aimed to evaluate the occurrence of AKI and use of kidney replacement therapy (KRT) in critical COVID-19, to assess patient and kidney outcomes and risk factors for AKI and differences in outcome when the diagnosis of AKI is based on urine output (UO) or on serum creatinine (sCr).

METHODS: Multicenter, retrospective cohort analysis of patients with critical COVID-19 in seven large hospitals in Belgium. AKI was defined according to KDIGO within 21 days after ICU admission. Multivariable logistic regression analysis was used to explore the risk factors for developing AKI and to assess the association between AKI and ICU mortality.

RESULTS: Of 1286 patients, 85.1% had AKI, and KRT was used in 9.8%. Older age, obesity, a higher APACHE II score and use of mechanical ventilation at day 1 of ICU stay were associated with an increased risk for AKI. After multivariable adjustment, all AKI stages were associated with ICU mortality. AKI was based on sCr in 40.1% and UO in 81.5% of patients. All AKI stages based on sCr and AKI stage 3 based on UO were associated with ICU mortality. Persistent AKI was present in 88.6% and acute kidney disease (AKD) in 87.6%. Rapid reversal of AKI yielded a better prognosis compared to persistent AKI and AKD. Kidney recovery was observed in 47.4% of surviving AKI patients.

CONCLUSIONS: Over 80% of critically ill COVID-19 patients had AKI. This was driven by the high occurrence rate of AKI defined by UO criteria. All AKI stages were associated with mortality (NCT04997915).

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Schaubroeck H, Vandenberghe W, Boer W, et al. Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium. Crit Care. 2022. PMID: 35879765. doi:10.1186/s13054-022-04086-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。